Treatment patterns for metastatic colorectal cancer in Spain.
Enrique ArandaE PoloC CampsA CarratoE Díaz-RubioV GuillemR LópezA AntónPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)
This study reveals inconsistencies regarding adherence to the recommendations of the ESMO guidelines for the management of mCRC in Spain. Improved adherence to the standard practice described in such guidelines for the determination of RAS and BRAF mutation statuses and the use of targeted therapies in first-line treatment should be considered to guarantee that patients can benefit from the best therapeutic approaches available.
Keyphrases
- metastatic colorectal cancer
- end stage renal disease
- clinical practice
- chronic kidney disease
- newly diagnosed
- ejection fraction
- healthcare
- primary care
- peritoneal dialysis
- prognostic factors
- type diabetes
- adipose tissue
- metabolic syndrome
- patient reported outcomes
- glycemic control
- patient reported
- solid phase extraction
- weight loss